These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Fixed drug eruption of the oral mucous membrane. Jain VK; Dixit VB; Archana Ann Dent; 1991; 50(1):9-11. PubMed ID: 1831337 [TBL] [Abstract][Full Text] [Related]
4. Drugs causing fixed eruptions: a study of 450 cases. Mahboob A; Haroon TS Int J Dermatol; 1998 Nov; 37(11):833-8. PubMed ID: 9865869 [TBL] [Abstract][Full Text] [Related]
5. Drugs causing fixed drug eruptions. Shukla SR Dermatologica; 1981; 163(2):160-3. PubMed ID: 6456950 [TBL] [Abstract][Full Text] [Related]
6. Contact sensitivity to oxyphenbutazone (Tanderil) and cross-sensitivity to phenylbutazone (Butazolidine). Krook G Contact Dermatitis; 1975 Dec; 1(6):385-6. PubMed ID: 139265 [No Abstract] [Full Text] [Related]
7. Topical provocation of fixed drug eruption. A study of 30 patients. Alanko K Contact Dermatitis; 1994 Jul; 31(1):25-7. PubMed ID: 7924289 [TBL] [Abstract][Full Text] [Related]
8. Topical provocation in 31 cases of fixed drug eruption: change of causative drugs in 10 years. Lee AY Contact Dermatitis; 1998 May; 38(5):258-60. PubMed ID: 9667442 [TBL] [Abstract][Full Text] [Related]
10. Cutaneous reactions to drugs: a series of in-patients during a five-year period. Stubb S; Heikkilä H; Kauppinen K Acta Derm Venereol; 1994 Jul; 74(4):289-91. PubMed ID: 7976089 [TBL] [Abstract][Full Text] [Related]
11. Prospective study of cutaneous drug reactions. Puavilai S; Timpatanapong P J Med Assoc Thai; 1989 Mar; 72(3):167-71. PubMed ID: 2525591 [TBL] [Abstract][Full Text] [Related]
12. Photopatch testing in seven cases of photosensitive drug eruptions. Lee AY; Joo HJ; Chey WY; Kim YG Ann Pharmacother; 2001 Dec; 35(12):1584-7. PubMed ID: 11793626 [TBL] [Abstract][Full Text] [Related]
14. A study of drug eruptions by provocative tests. Das J; Mandal AC Indian J Dermatol Venereol Leprol; 2001; 67(5):238-9. PubMed ID: 17664759 [TBL] [Abstract][Full Text] [Related]
15. Fixed drug eruption. Current concepts. Sehgal VN; Gangwani OP Int J Dermatol; 1987 Mar; 26(2):67-74. PubMed ID: 2952612 [No Abstract] [Full Text] [Related]
16. Drug related clinical pattern in fixed drug eruption. Ozkaya-Bayazit E; Bayazit H; Ozarmagan G Eur J Dermatol; 2000 Jun; 10(4):288-91. PubMed ID: 10846256 [TBL] [Abstract][Full Text] [Related]
17. Drug re-challenges in cutaneous adverse drug reactions: information and effectiveness in the long-term management of patients. Waton J; Pouget-Jasson C; Loos-Ayav C; Trechot P; Bursztejn AC; Schmutz JL; Barbaud A Allergy; 2011 Jul; 66(7):941-7. PubMed ID: 21303375 [TBL] [Abstract][Full Text] [Related]
18. Usefulness of skin testing in cutaneous drug eruptions in routine practice. Tchen T; Reguiaï Z; Vitry F; Arnoult E; Grange A; Florent G; Bernard P Contact Dermatitis; 2009 Sep; 61(3):138-44. PubMed ID: 19780771 [TBL] [Abstract][Full Text] [Related]
19. Skin tests in the diagnosis of adverse drug reactions. Stingeni L; Bianchi L; Tramontana M; Pigatto PD; Patruno C; Corazza M; Foti C; Fabbrocini G; Micali G; Romita P; Napolitano M; Hansel K G Ital Dermatol Venereol; 2020 Oct; 155(5):602-621. PubMed ID: 32938165 [TBL] [Abstract][Full Text] [Related]